For: | Feng S, Song JD. Determination of β-glucuronidase in human colorectal carcinoma cell lines. World J Gastroenterol 1997; 3(4): 251-252 [PMID: 27053883 DOI: 10.3748/wjg.v3.i4.251] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v3/i4/251.htm |
Number | Citing Articles |
1 |
Carsten Lange, Amanda Machado Weber, Ronny Schmidt, Christoph Schroeder, Thomas Strowitzki, Ariane Germeyer, Jae-Wook Jeong. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line. PLOS ONE 2021; 16(3): e0248103 doi: 10.1371/journal.pone.0248103
|
2 |
In-Cheol Sun, Hong Yeol Yoon, Dong-Kwon Lim, Kwangmeyung Kim. Recent Trends in In Situ Enzyme-Activatable Prodrugs for Targeted Cancer Therapy. Bioconjugate Chemistry 2020; 31(4): 1012 doi: 10.1021/acs.bioconjchem.0c00082
|
3 |
V. A. Shiva Ayyadurai, Prabhakar Deonikar, Christine Fields. Mechanistic Understanding of D-Glucaric Acid to Support Liver Detoxification Essential to Muscle Health Using a Computational Systems Biology Approach. Nutrients 2023; 15(3): 733 doi: 10.3390/nu15030733
|
4 |
MichaelRusselle S. Alvarez, Junie Billones, Chun-Hung Lin, Francisco Heralde. Plectranthus amboinicus (Spreng.) Semi-purified Fractions with Selective β-Glucuronidase Inhibition Elucidated with gas chromatography-mass spectrometry and in silico docking. Pharmacognosy Magazine 2021; 17(6): 268 doi: 10.4103/pm.pm_149_21
|
5 |
Kai-Wen Cheng, Chih-Hua Tseng, Cherng-Chyi Tzeng, Yu-Lin Leu, Ta-Chun Cheng, Jaw-Yuan Wang, Jia-Ming Chang, Yun-Chi Lu, Chiu-Min Cheng, I-Ju Chen, Yi-An Cheng, Yeh-Long Chen, Tian-Lu Cheng. Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo. Pharmacological Research 2019; 139: 41 doi: 10.1016/j.phrs.2018.10.029
|
6 |
Seo Young Yang, Nguyen Viet Phong. Phenolic compounds from the stems of Zanthoxylum piperitum and their inhibition of β-glucuronidase: Enzyme kinetics, molecular docking, and molecular dynamics analysis. Journal of Molecular Structure 2024; 1317: 139117 doi: 10.1016/j.molstruc.2024.139117
|
7 |
Xinyu Li, Fangjun Huo, Yongbin Zhang, Fangqin Cheng, Caixia Yin. Enzyme-activated prodrugs and their release mechanisms for the treatment of cancer. Journal of Materials Chemistry B 2022; 10(29): 5504 doi: 10.1039/D2TB00922F
|
8 |
Gang Tang, Linyu Zhang. Update on Strategies of Probiotics for the Prevention and Treatment of Colorectal Cancer. Nutrition and Cancer 2022; 74(1): 27 doi: 10.1080/01635581.2020.1865420
|
9 |
Mélanie Mahé, Tiffany J. Rios-Fuller, Andrea Karolin, Robert J. Schneider. Genetics of enzymatic dysfunctions in metabolic disorders and cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1230934
|
10 |
Harlei Martin, Laura Ramírez Lázaro, Thorfinnur Gunnlaugsson, Eoin M. Scanlan. Glycosidase activated prodrugs for targeted cancer therapy. Chemical Society Reviews 2022; 51(23): 9694 doi: 10.1039/D2CS00379A
|